Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 575 of 945 entries
View as:
Phase: N/A
Priority: Normal
Start: 03/31/16
End: 07/20/18
Due: 07/20/19
Phase: N/A
Priority: Normal
Start: 10/03/22
End: 10/31/24
Due: 10/31/25
Phase: N/A
Priority: Normal
Start: 03/26/20
End: 05/13/20
Due: 05/13/21
Phase: N/A
Priority: Normal
Start: 08/20/20
End: 12/31/25
Due: 12/31/26
Phase: N/A
Priority: Normal
Start: 07/15/20
End: 12/15/23
Due: 12/15/24
Phase: N/A
Priority: Normal
Start: 10/31/06
End: 03/31/08
Due: 03/31/09
Phase: N/A
Priority: Normal
Start: 09/01/22
End: 11/01/25
Due: 11/01/26
Phase: N/A
Priority: Normal
Start: 09/01/20
End: 12/31/23
Due: 12/31/24
Phase: N/A
Priority: Normal
Start: 08/31/13
End: 01/15/18
Due: 01/15/19
Transmural Collaborative Care Model for CVRM and Medication Review for Patients Using Antipsychotics
Phase: N/A
Priority: Normal
Start: 03/01/23
End: 11/01/24
Due: 11/01/25
Phase: N/A
Priority: Normal
Start: -
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 05/31/06
End: 07/31/07
Due: 07/31/08
Phase: N/A
Priority: Normal
Start: 01/31/08
End: 10/31/10
Due: 10/31/11
Phase: N/A
Priority: Normal
Start: 11/30/05
End: 12/31/06
Due: 12/31/07
Phase: N/A
Priority: Normal
Start: 02/14/22
End: 12/31/22
Due: 12/31/23
Phase: N/A
Priority: Normal
Start: 09/30/08
End: 06/30/13
Due: 06/30/14
Phase: N/A
Priority: Normal
Start: 02/28/18
End: 12/31/19
Due: 12/31/20
Phase: N/A
Priority: Normal
Start: 02/01/18
End: 09/01/19
Due: 09/01/20
Phase: N/A
Priority: Normal
Start: 08/31/10
End: 10/31/11
Due: 10/31/12
Phase: N/A
Priority: Normal
Start: 12/31/08
End: 05/31/12
Due: 05/31/13
Phase: N/A
Priority: Normal
Start: 11/30/10
End: 04/30/14
Due: 04/30/15
Phase: N/A
Priority: Normal
Start: 09/01/19
End: 09/30/23
Due: 09/30/24
Phase: N/A
Priority: Normal
Start: 07/31/05
End: 07/31/07
Due: 07/31/08
Phase: N/A
Priority: Normal
Start: 06/11/18
End: 06/11/19
Due: 06/11/20
Phase: N/A
Priority: Normal
Start: 11/16/15
End: 06/14/21
Due: 06/14/22